Compounds > org 31710
Page last updated: 2024-09-05

org 31710 and org 33628

org 31710 has been researched along with org 33628 in 2 studies

Compound Research Comparison

Studies
(org 31710)		Trials
(org 31710)		Recent Studies (post-2010)
(org 31710)		Studies
(org 33628)		Trials
(org 33628)		Recent Studies (post-2010) (org 33628)
3836501

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Gooyer, ME; Deckers, GH; Dijkema, R; Kloosterboer, HJ; Orlemans, EO; Schoonen, WG1
Hanssen, RG; Korver, GH; Mulders, TM; Verbost, PM1

Reviews

1 review(s) available for org 31710 and org 33628

ArticleYear
ORG 33628 and ORG 31710 to control vaginal bleeding in progestin-only contraceptive regimens.
    Seminars in reproductive medicine, 2005, Volume: 23, Issue:1

    Topics: Animals; Contraceptive Agents; Drug Administration Schedule; Drug Combinations; Estrenes; Estrous Cycle; Female; Furans; Humans; Menstruation Disturbances; Progestins; Randomized Controlled Trials as Topic

2005

Other Studies

1 other study(ies) available for org 31710 and org 33628

ArticleYear
Pharmacological properties of a new selective antiprogestagen: Org 33628.
    Annals of the New York Academy of Sciences, 1995, Jun-12, Volume: 761

    Topics: Adrenal Glands; Animals; Cell Line; Estrenes; Female; Furans; Gonanes; Guinea Pigs; Humans; In Vitro Techniques; Mifepristone; Ovulation; Pregnancy; Progestins; Receptors, Cell Surface; Receptors, Progesterone; Structure-Activity Relationship

1995